IRE Elit files to market tracer generator

IRE Elit has filed an application with the European Medicines Agency (EMA) to market its Galli Eo generator to produce the PET radiopharmaceuticals gallium-68 (Ga-68) and germanium-68 (Ge-68).

The generator is designed to extract the positron-emitting isotope Ga-68 of gallium from a source of decaying germanium-68 used for diagnostic procedures.

Its major application would be in oncology, where development and availability of new 68-Ga-agents, such as prostate-specific membrane antigen (PSMA) for prostate cancer detection, have increased in recent years.

Page 1 of 545
Next Page